Prof. Dr. Mutlu DemirayMedical Oncology

Dr. Ebru Gül Karakoç

Medical Consultant

Dr. Ebru Gül Karakoç is a Medical Doctor and MBA graduate with over 20 years of leadership experience in Medical Affairs, clinical trials, and pharmaceutical regulations. She is highly specialized in Precision Oncology and Cancer Genomics, with active involvement in Molecular Tumor Boards (MTB) and strategic healthcare consulting.

Her work focuses on bridging clinical practice with the biopharma industry, leveraging genomics-driven insights to optimize personalized cancer treatment strategies. She has led international collaborations, launched innovative genomic products, and contributed to improving patient outcomes through data-driven oncology approaches.

Her overarching goal is to integrate precision oncology into routine clinical practice while fostering global scientific collaboration and advancing translational cancer research.

Dr. Ebru Gül Karakoç

Professional career

2022 – Present
Consultant / Precision Oncology Specialist
Medicana Health Group, Oncology Department
2018 – 2021
Foundation Medicine (FMI) Science Leader
Roche · International & local clinical trials (CUPISCO, TROIA)
2014 – 2018
Medical Information & Pharmacovigilance Manager
Roche
2005 – 2014
Senior Medical Manager
Roche
2002 – 2005
Medical Specialist
Santa Farma Pharmaceuticals
2000 – 2002
Research Assistant
Cerrahpaşa Medical Faculty, Department of Public Health

Academic career

2016
MBA (Executive)
Koç University
1998
Doctor of Medicine (MD)
Ege University School of Medicine

Scientific publications

International network

Areas of expertise

Precision Oncology & Cancer GenomicsMolecular Tumor Boards (MTB)Comprehensive Genomic ProfilingClinical Trial Design & ImplementationMedical Strategy & Scientific LeadershipPersonalized Treatment OptimizationCross-functional & International Project Management